These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 8266016)

  • 1. Sulglycotide in the prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal mucosal injury. A controlled double-blind, double-dummy, randomized endoscopic study versus placebo in rheumatic patients.
    Bianchi Porro G; Montrone F; Petrillo M; Caruso I; Ardizzone S
    Scand J Gastroenterol; 1993 Oct; 28(10):875-8. PubMed ID: 8266016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
    Bianchi Porro G; Lazzaroni M; Petrillo M
    Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention with sucralfate gel of NSAID-induced gastroduodenal damage in arthritic patients.
    Miglioli M; Bianchi Porro G; Vaira D; Menegatti M; Brunetti G; Petrillo M; Ardizzone S; Frizziero L; Montrone F; Grandinetti G
    Am J Gastroenterol; 1996 Nov; 91(11):2367-71. PubMed ID: 8931419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of omeprazole on healing and appearance of small gastric and duodenal lesions during dosing with diclofenac in healthy subjects.
    Dorta G; Nicolet M; Vouillamoz D; Margalith D; Saraga E; Bouzourene H; Häcki WH; Stolte M; Blum AL; Armstrong D
    Aliment Pharmacol Ther; 2000 May; 14(5):535-41. PubMed ID: 10792115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of pantoprazole in the prevention of peptic ulcers, induced by non-steroidal anti-inflammatory drugs: a prospective, placebo-controlled, double-blind, parallel-group study.
    Bianchi Porro G; Lazzaroni M; Imbesi V; Montrone F; Santagada T
    Dig Liver Dis; 2000 Apr; 32(3):201-8. PubMed ID: 10975769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine.
    Ehsanullah RS; Page MC; Tildesley G; Wood JR
    BMJ; 1988 Oct; 297(6655):1017-21. PubMed ID: 3142593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs. Misoprostol Study Group.
    Graham DY; White RH; Moreland LW; Schubert TT; Katz R; Jaszewski R; Tindall E; Triadafilopoulos G; Stromatt SC; Teoh LS
    Ann Intern Med; 1993 Aug; 119(4):257-62. PubMed ID: 8328732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonsteroidal antiinflammatory drugs for cancer pain: comparison between misoprostol and ranitidine in prevention of upper gastrointestinal damage.
    Valentini M; Cannizzaro R; Poletti M; Bortolussi R; Fracasso A; Testa V; Sozzi M; Fornasarig M; Bortoluzzi F; Grazioli I
    J Clin Oncol; 1995 Oct; 13(10):2637-42. PubMed ID: 7595718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of gastroduodenal damage with omeprazole in patients receiving continuous NSAIDs treatment. A double blind placebo controlled study.
    Bianchi Porro G; Lazzaroni M; Petrillo M; Manzionna G; Montrone F; Caruso I
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):43-7. PubMed ID: 9615264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal mucosal injury: risk factors for serious complications.
    Koch M; Dezi A; Tarquini M; Capurso L
    Dig Liver Dis; 2000 Mar; 32(2):138-51. PubMed ID: 10975790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of NSAID-gastropathy.
    Ardizzone S; Bianchi Porro G
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():33-6. PubMed ID: 9032581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs.
    Taha AS; Hudson N; Hawkey CJ; Swannell AJ; Trye PN; Cottrell J; Mann SG; Simon TJ; Sturrock RD; Russell RI
    N Engl J Med; 1996 May; 334(22):1435-9. PubMed ID: 8618582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs.
    Dajani EZ; Agrawal NM
    Dig Dis; 1995 Jan; 13 Suppl 1():48-61. PubMed ID: 7697902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of sulglycotide in the prevention of duodenal ulcer relapse.
    De Conca V; Saccomanno S; Dodero M; Aste H
    Eur J Gastroenterol Hepatol; 1995 Jan; 7(1):25-8. PubMed ID: 7866806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term non-steroidal anti-inflammatory drug (NSAID) therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial.
    Sugano K; Kontani T; Katsuo S; Takei Y; Sakaki N; Ashida K; Mizokami Y; Asaka M; Matsui S; Kanto T; Soen S; Takeuchi T; Hiraishi H; Hiramatsu N
    J Gastroenterol; 2012 May; 47(5):540-52. PubMed ID: 22388884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diclofenac/misoprostol compared with diclofenac in the treatment of osteoarthritis of the knee or hip: a randomized, placebo controlled trial. Arthrotec Osteoarthritis Study Group.
    Bocanegra TS; Weaver AL; Tindall EA; Sikes DH; Ball JA; Wallemark CB; Geis GS; Fort JG
    J Rheumatol; 1998 Aug; 25(8):1602-11. PubMed ID: 9712107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users.
    Cullen D; Bardhan KD; Eisner M; Kogut DG; Peacock RA; Thomson JM; Hawkey CJ
    Aliment Pharmacol Ther; 1998 Feb; 12(2):135-40. PubMed ID: 9692687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sulglicotide in the prevention of gastric disease induced by NSAID. Double-blind controlled study versus placebo].
    Magarò M; Altomonte L; Zoli A; Mirone L; Wielmarin A; Massari M; Destito G; Nazzari M; Psilogenis M
    Minerva Dietol Gastroenterol; 1989; 35(1):27-30. PubMed ID: 2725926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years.
    Goldstein JL; Aisenberg J; Lanza F; Schwartz H; Sands GH; Berger MF; Pan S
    Clin Ther; 2006 Mar; 28(3):340-51. PubMed ID: 16750449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An endoscopic study of gastroduodenal lesions induced by nonsteroidal anti-inflammatory drugs.
    Cheatum DE; Arvanitakis C; Gumpel M; Stead H; Geis GS
    Clin Ther; 1999 Jun; 21(6):992-1003. PubMed ID: 10440623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.